The H1-5 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to achieve targeted disruption of the H1-5 gene in the HEK293T host cell line. This product provides a heterogeneous pool of cells carrying diverse loss-of-function mutations in the H1-5 locus, enabling researchers to examine linker histone-dependent phenotypes without clonal selection artifacts. The polyclonal format is particularly suited for pooled functional screens, bulk epigenomic profiling, and studies requiring representation of the full spectrum of editing outcomes. As a non-clonal population, it models the natural variability in knockout efficiency and compensatory mechanisms, offering a robust tool for investigating H1-5 biology in an isogenic background.
HEK293T cells are a widely utilized human embryonic kidney-derived epithelial cell line that stably expresses the SV40 large T antigen, which facilitates episomal replication of plasmids containing the SV40 origin and enhances recombinant protein production. Originally derived from HEK293 cells, HEK293T is highly transfectable and has become a workhorse for transient gene expression, viral packaging, and signaling pathway dissection. The cell line retains many characteristics of renal proximal tubular epithelium, making it relevant for studies of kidney cell biology, oncogenic transformation, and epigenetic regulation. Its rapid growth rate and robust performance in high-throughput assays further extend its utility in drug discovery and functional genomics.
H1-5 encodes a member of the linker histone H1 family, which binds to nucleosomal core particles and internucleosomal linker DNA, stabilizing higher-order chromatin folding and restricting DNA accessibility. This architectural role orchestrates global transcriptional control, DNA replication dynamics, and apoptotic chromatin condensation. H1-5 function is integrated into signaling networks: it is regulated by upstream factors such as CDK1-mediated phosphorylation, E2F1 transcriptional control, and p53-dependent pathways, and its loading is facilitated by histone chaperones including ASF1. Downstream, H1-5 influences heterochromatin maintenance, Hox gene silencing, and global gene expression patterns. It physically interacts with core histones H2A, H2B, H3, and H4, as well as histone chaperones NAP1 and NAP2, DNA methyltransferases, and HMG proteins. Through these interactions, H1-5 contributes to the coordinated regulation of chromatin organization, epigenetic memory, and genome stability.
In the HEK293T background, disruption of H1-5 allows direct interrogation of linker histone functions in a cell type that supports robust transcriptional and replicative activity. The SV40 large T antigen-driven proliferation model accentuates the need for proper chromatin compaction to maintain genome integrity, potentially revealing synthetic vulnerabilities when H1-5 is absent. This model is particularly valuable for dissecting mechanistic links between linker histone dynamics and epigenetic dysregulation observed in cancers, where H1-5 expression is frequently altered. The polyclonal nature of the knockout population mimics heterogeneous cellular contexts encountered in tumor microenvironments, providing a realistic platform for assessing chromatin-related therapeutic targets.
Key applications of these cells include chromatin accessibility profiling by ATAC-seq, locus-specific chromatin immunoprecipitation (ChIP-qPCR), and co-immunoprecipitation to map H1-5 interaction networks. They are also suitable for reporter gene assays to quantify changes in transcriptional regulation, immunofluorescence to visualize chromatin structure, and RT-qPCR or Western blotting to confirm H1-5 loss. Researchers can employ this model to study epigenetic mechanisms, DNA repair fidelity, and the role of linker histones in cancer biology, particularly in ovarian and breast cancers where H1-5 is dysregulated. For further technical information or ordering details, please contact Ascent Research.
